研究者検索結果一覧 小澤 敬也 小澤 敬也オザワ ケイヤ (Keiya Ozawa) ダウンロードする帳票の形式を下記より選択して下さい 「教育研究等環境」形式 「文科省帳票様式第4号 ①履歴書」形式 「文科省帳票様式第4号 ②教育研究業績書」形式 基本情報 所属自治医科大学(JMU) 教授学位医学博士(東京大学)J-GLOBAL ID200901030330125009researchmap会員ID0000018135 研究キーワード 6 AAVベクター 造血幹細胞 遺伝子治療 AAV vector Hematopietic stem cell gene therapy 研究分野 1 ライフサイエンス / 血液、腫瘍内科学 / 経歴 72 2002年 4月 自治医科大学分子病態治療研究センター 2001年3月 (輸血部より改称)(部長兼任は2001年3月まで) 2001年 4月 東北大学大学院医学系研究科大学院非常勤講師 2000年10月 月 自治医科大学内科学講座血液学部門主任教授 2000年 4月 自治医科大学総合診療部医員(兼任) もっとみる 学歴 2 - 1977年 東京大学 医学部 医学科 - 1977年 University of Tokyo Faculty of Medicine 委員歴 7 2000年 - 2001年 国際実験血液学会 ISEH Standing Scientific Program Committee Member 1999年 日本癌学会 評議員 1996年 がん分子標的治療研究会 世話人 1994年 日本遺伝子治療学会 幹事、評議員、プログラム委員 1994年 日本ウイルス学会 将来計画委員会(将来構想検討委員会)委員 もっとみる 受賞 2 1999年 平成11年度日本医師会医学研究助成賞 1999. Grant-in-Aid of The Japan Medical Association MISC 501 Chronic bone marrow failure due to persistent B19 parvovirus infection. N.Engl.J.Med.317:287-294,1987. Charged-to-alanine scanning mutagenesis of N-terminal half of adeno-associated virus type 2 Rep78 protein. J.Virol.(in press) Charged-to alanine scanning mutagenesis of the N-terminal half of adeno-associated virus type 2 Rep78 protein. J. Virol.73: 2682-2693, 1999. Characterization of transformed hematopoietic cells afier activated ras gene transfection. In, Myelodysplastic Syndromes: Advances in Research and Treatment. Elsevier Science B.V.p.237-243,1995. Characterization of the kinase activity essential for tyrosine phosphorylation of pl30cas in fibroblasts. Oncogene14:1419-1426,1997. Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroidbone marrow cell cultures. J.Virol.61:2627-2630, 1987. Characteristics of granulocyte-macrophage colony formation in patients with chronic myelomonocytic Leukemia Stem Cells1:345-353,1981 Changes in hematopoiesis-supporting ability of C3HIOTl/2 mouse embryo fibroblasts during differentiation. Blood 81:1184-l192,1993. Case report: Alternation therapy with antileukemic agents and recombinant human granulocyte colony-stimulating factor for RAEB in transformation. Am.J.Med.Sci.303:316-318,1992. Case report. Hemophagocytosis as a para-neoplastic syndrome in NK cell leukemia. Int.J.Hematol.64:135-142,1996. Biological activity of C-terminus modified version of human granulocyte colony-stimulating factor. Biochem.Biophys.Res.Commun.(in press) Binding of membrane-anchored macrophage colony-stimulating factor (M-CSF) to its receptor mediates specific adhesion between stromal cells and M-CSF receptor-bearing hematopoietic cells. Blood 82:2634-2640,1993. Behavioral recovery in 6-hydroxydopamine-lesioned rats by cotransduction of striatum with tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes using two separate adeno-associated virus vectors. Hum. Gene Ther.9:2527-2535,1998. Basic studies toward hematopoietic stem cell gene therapy. In, Cell Therapy (ed. by Ikeda, Y., Hata, J., Koyasu, S., Kawakami, Y., Hattori, Y.) Springer-Verlag, Tokyo, p.159-169, 2000. B19 parvovirus replicates in erythroid leukemia cells in vitro. J.Infect.Dis.160:548-549,1989. Autologous peripheral blood stem cell transplantation for adults with B-lineage acute lymphoblastic leukemia: a pilot study. Leukemia Lymphoma 38: 103-111, 2000. Autologous bone marrow transplantation for patients with advanced chronic myelogenous leukemia. Int.J.Hematol.66:493-503,1997. Apoptosis-mediated regulation of recombinant human granulocyte eolony-stimulating factor production by genetically engineered fibroblasts. Gene Ther.5:923-929,1998. Adult T-cell lenkemia developing during immunosuppressive treatment in a renal transplant recipient. Am.J.Hematol.41:292-294,1992. Adhesion of NFS-60 myeloid leukemia cells to MC3T3-G2/PA6 stromal cells induces granulocyte colony-stimulating factor production. Blood 84:415-420,l994. Adeno-associated virus vector-mediated bcl-2 gene transfer into post-ischemic gerbil brain in vivo: prospects for gene therapy of ischemia-induced neuronal death. Gene Ther. 7: 1244-1249, 2000. Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J.Virol.71:7951-7959,1997. Adeno-associated virus (AAV) vectors and gene therapy of Parkinson's disease. In, Progress in Gene Therapy-Basic and Clinical Frontiers. (ed. by Bertolotti, R., Parvez, S. H., and Nagatsu, T.) VSP BV, Natherlands, pp.289-306, 2000. Acquisition of IL-3-independence in FDC-P2 cells after transfection with the activated c-H-rasgene using a bovine papillomavirus-based plasmid vector. Blood 80:3198-3204,1992. Acceleration of neutrophilic granulocyte recovery in bone recombinant human granulocyte colony marrow transplanted patients by administration. Lancetii:38-39, 1988. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor. Transplantation59:1596-1600,1995. A selective amplifier gene for tamoxifen-inducible expansion of hematopoietic cells. J. Gene Med. 1:236-244, 1999. A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia. Blood 78:3125-3127,1991 A novel strategy for the tumor angiogenesis-targeted gene therapy: Generation of angiostatin endogenous plasminogen by protease gene transfer. Cancer Gene Ther. 7: 589-596, 2000. A novel selective amplifier gene for hematopoietic stem cell gene therapy. Cancer Res.Ther.Contr.7:27-31,1998. A novel gene (drad-J) expressed in hematopoiesis-supporting stromal cell lines, ST2, PA6 and A54 preadipocytes:Use of mRNA differential display Stem Cells15:334-339,1997. A novel dicistronic AAV (adeno-associated virus) vector using a short IRES (internal ribosome entry site) segment derived from hepatitis C virus genome. Gene 200: 157-162, 1997. A new method for permanent preparations of hemopoietic cells in methylcellulose medium. Hematol.10:145-150,1982. A new apoptotic pathway for the complement factor B-derived fragment Bbeta. J. Cell. Physiol. 185: 280-292, 2000. A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction. Blood 96: 941-949, 2000. A case of myelodysplastic syndrome (refractory anemia) transforming into acute leukemia with monosomy 7 afier administration of granulocyte colony-stimulating factor. In, Myelodysplastic Syndromes: Advances in Research and Treatment. Elsevier Science B.V, p.357-359, 1995. A case of bilateral heel ulcers associated with hydroxyurea therapy for chronic myelogenous leukemia. Jpn. J. Clin. Oncol. 30: 159-162, 2000. A Stu I polymorphism in the human granulocyte colony-stimulating factor gene. Nucl.Acid Res.17:7544,1989. A functional role of mitogen-activated protein kinases, Erk1 and Erk2, in the differentiation of a human leukemia cell line, UT-7/GM: A possible key factor for cell fate determination toward erythroid and megakaryocytic lineages. Int. J. Hematol. 73 : 78-83, 2001. g-Rays enhance rAAV-mediated transgene expression and cytocidal effect of AAV-HSVtk / ganciclovir on cancer cells. Cancer Gene Ther. 8 : 99-106, 2001 Forkhead family transcription factor FKHRL1 is expressed in human megakaryocytes and regulates cell cycling as a downstream molecule of TPO signaling. J. Biol. Chem. 276 : 15082-15089, 2001. Morphological and physiological restorations of hereditary form of dilated cardiomyopathy by somatic gene therapy. Biochem. Biophys. Res. Commun. 284 : 431-435, 2001. Antitumor effect of beta2-microglobulin in leukemic cell-bearing mice via apoptosis-inducing activity : activation of caspase-3 and nuclear factor-kappaB. Cancer Res. 61 : 4414-4417, 2001. CD13 is the resistance mechanism for endothelial interleukin-8 inducing apoptosis. In, Cell-Surface Aminopeptidases : Basic and Clinical Aspects. (ed. by Mizutani, S.and Turner, A.J.) Elsevier Science B.V., p. 177-184, 2001. Adeno-associated virus-mediated transfer of endothelial nitric oxide synthase gene reduces vasoconstrictive response. Exp. Clin. Cardiol. 6 : 50-55, 2001. A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus. Hum. Gene Ther. 12 : 1047-1061, 2001. Targeted integration of foreign dna into a defined locus on chromosome 19 in K562 cells using MV-derived components. Int. J. Hematol. 73 : 469-475, 2001. Adeno-associated virus-mediated transfer of endothelial nitric oxide synthase gene inhibits protein synthesis of rat ventricular cardiomyocytes. Cardiovas. Drug Ther. 15 : 19-24, 2001. Colon cancer with meningeal carcinomatosis and myelodysplastic syndrome in a patient who underwent intensive chemotherapy for acute myelogenous leukemia : a case report. Jpn. J. Clin. Oncol. 31: 221-225, 2001. beta2-Microglobulin identified as an apoptosis-inducing factor and its characterization. Blood 94: 2744-2753, 1999. «56789» 所属学協会 40 日本再生医療学会 米国微生物学会 米国血液学会 米国科学振興協会 米国医学研究連合 もっとみる 共同研究・競争的資金等の研究課題 6 遺伝子治療 ミレニアム・プロジェクト 遺伝子治療 厚生労働科学研究費補助金 遺伝子治療 科学研究費補助金 Gene therapy Millennium Project Gene therapy Health and Labour Sciences Research Grants もっとみる
小澤 敬也オザワ ケイヤ (Keiya Ozawa) ダウンロードする帳票の形式を下記より選択して下さい 「教育研究等環境」形式 「文科省帳票様式第4号 ①履歴書」形式 「文科省帳票様式第4号 ②教育研究業績書」形式 基本情報 所属自治医科大学(JMU) 教授学位医学博士(東京大学)J-GLOBAL ID200901030330125009researchmap会員ID0000018135 研究キーワード 6 AAVベクター 造血幹細胞 遺伝子治療 AAV vector Hematopietic stem cell gene therapy 研究分野 1 ライフサイエンス / 血液、腫瘍内科学 / 経歴 72 2002年 4月 自治医科大学分子病態治療研究センター 2001年3月 (輸血部より改称)(部長兼任は2001年3月まで) 2001年 4月 東北大学大学院医学系研究科大学院非常勤講師 2000年10月 月 自治医科大学内科学講座血液学部門主任教授 2000年 4月 自治医科大学総合診療部医員(兼任) もっとみる 学歴 2 - 1977年 東京大学 医学部 医学科 - 1977年 University of Tokyo Faculty of Medicine 委員歴 7 2000年 - 2001年 国際実験血液学会 ISEH Standing Scientific Program Committee Member 1999年 日本癌学会 評議員 1996年 がん分子標的治療研究会 世話人 1994年 日本遺伝子治療学会 幹事、評議員、プログラム委員 1994年 日本ウイルス学会 将来計画委員会(将来構想検討委員会)委員 もっとみる 受賞 2 1999年 平成11年度日本医師会医学研究助成賞 1999. Grant-in-Aid of The Japan Medical Association MISC 501 Chronic bone marrow failure due to persistent B19 parvovirus infection. N.Engl.J.Med.317:287-294,1987. Charged-to-alanine scanning mutagenesis of N-terminal half of adeno-associated virus type 2 Rep78 protein. J.Virol.(in press) Charged-to alanine scanning mutagenesis of the N-terminal half of adeno-associated virus type 2 Rep78 protein. J. Virol.73: 2682-2693, 1999. Characterization of transformed hematopoietic cells afier activated ras gene transfection. In, Myelodysplastic Syndromes: Advances in Research and Treatment. Elsevier Science B.V.p.237-243,1995. Characterization of the kinase activity essential for tyrosine phosphorylation of pl30cas in fibroblasts. Oncogene14:1419-1426,1997. Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroidbone marrow cell cultures. J.Virol.61:2627-2630, 1987. Characteristics of granulocyte-macrophage colony formation in patients with chronic myelomonocytic Leukemia Stem Cells1:345-353,1981 Changes in hematopoiesis-supporting ability of C3HIOTl/2 mouse embryo fibroblasts during differentiation. Blood 81:1184-l192,1993. Case report: Alternation therapy with antileukemic agents and recombinant human granulocyte colony-stimulating factor for RAEB in transformation. Am.J.Med.Sci.303:316-318,1992. Case report. Hemophagocytosis as a para-neoplastic syndrome in NK cell leukemia. Int.J.Hematol.64:135-142,1996. Biological activity of C-terminus modified version of human granulocyte colony-stimulating factor. Biochem.Biophys.Res.Commun.(in press) Binding of membrane-anchored macrophage colony-stimulating factor (M-CSF) to its receptor mediates specific adhesion between stromal cells and M-CSF receptor-bearing hematopoietic cells. Blood 82:2634-2640,1993. Behavioral recovery in 6-hydroxydopamine-lesioned rats by cotransduction of striatum with tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes using two separate adeno-associated virus vectors. Hum. Gene Ther.9:2527-2535,1998. Basic studies toward hematopoietic stem cell gene therapy. In, Cell Therapy (ed. by Ikeda, Y., Hata, J., Koyasu, S., Kawakami, Y., Hattori, Y.) Springer-Verlag, Tokyo, p.159-169, 2000. B19 parvovirus replicates in erythroid leukemia cells in vitro. J.Infect.Dis.160:548-549,1989. Autologous peripheral blood stem cell transplantation for adults with B-lineage acute lymphoblastic leukemia: a pilot study. Leukemia Lymphoma 38: 103-111, 2000. Autologous bone marrow transplantation for patients with advanced chronic myelogenous leukemia. Int.J.Hematol.66:493-503,1997. Apoptosis-mediated regulation of recombinant human granulocyte eolony-stimulating factor production by genetically engineered fibroblasts. Gene Ther.5:923-929,1998. Adult T-cell lenkemia developing during immunosuppressive treatment in a renal transplant recipient. Am.J.Hematol.41:292-294,1992. Adhesion of NFS-60 myeloid leukemia cells to MC3T3-G2/PA6 stromal cells induces granulocyte colony-stimulating factor production. Blood 84:415-420,l994. Adeno-associated virus vector-mediated bcl-2 gene transfer into post-ischemic gerbil brain in vivo: prospects for gene therapy of ischemia-induced neuronal death. Gene Ther. 7: 1244-1249, 2000. Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J.Virol.71:7951-7959,1997. Adeno-associated virus (AAV) vectors and gene therapy of Parkinson's disease. In, Progress in Gene Therapy-Basic and Clinical Frontiers. (ed. by Bertolotti, R., Parvez, S. H., and Nagatsu, T.) VSP BV, Natherlands, pp.289-306, 2000. Acquisition of IL-3-independence in FDC-P2 cells after transfection with the activated c-H-rasgene using a bovine papillomavirus-based plasmid vector. Blood 80:3198-3204,1992. Acceleration of neutrophilic granulocyte recovery in bone recombinant human granulocyte colony marrow transplanted patients by administration. Lancetii:38-39, 1988. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor. Transplantation59:1596-1600,1995. A selective amplifier gene for tamoxifen-inducible expansion of hematopoietic cells. J. Gene Med. 1:236-244, 1999. A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia. Blood 78:3125-3127,1991 A novel strategy for the tumor angiogenesis-targeted gene therapy: Generation of angiostatin endogenous plasminogen by protease gene transfer. Cancer Gene Ther. 7: 589-596, 2000. A novel selective amplifier gene for hematopoietic stem cell gene therapy. Cancer Res.Ther.Contr.7:27-31,1998. A novel gene (drad-J) expressed in hematopoiesis-supporting stromal cell lines, ST2, PA6 and A54 preadipocytes:Use of mRNA differential display Stem Cells15:334-339,1997. A novel dicistronic AAV (adeno-associated virus) vector using a short IRES (internal ribosome entry site) segment derived from hepatitis C virus genome. Gene 200: 157-162, 1997. A new method for permanent preparations of hemopoietic cells in methylcellulose medium. Hematol.10:145-150,1982. A new apoptotic pathway for the complement factor B-derived fragment Bbeta. J. Cell. Physiol. 185: 280-292, 2000. A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction. Blood 96: 941-949, 2000. A case of myelodysplastic syndrome (refractory anemia) transforming into acute leukemia with monosomy 7 afier administration of granulocyte colony-stimulating factor. In, Myelodysplastic Syndromes: Advances in Research and Treatment. Elsevier Science B.V, p.357-359, 1995. A case of bilateral heel ulcers associated with hydroxyurea therapy for chronic myelogenous leukemia. Jpn. J. Clin. Oncol. 30: 159-162, 2000. A Stu I polymorphism in the human granulocyte colony-stimulating factor gene. Nucl.Acid Res.17:7544,1989. A functional role of mitogen-activated protein kinases, Erk1 and Erk2, in the differentiation of a human leukemia cell line, UT-7/GM: A possible key factor for cell fate determination toward erythroid and megakaryocytic lineages. Int. J. Hematol. 73 : 78-83, 2001. g-Rays enhance rAAV-mediated transgene expression and cytocidal effect of AAV-HSVtk / ganciclovir on cancer cells. Cancer Gene Ther. 8 : 99-106, 2001 Forkhead family transcription factor FKHRL1 is expressed in human megakaryocytes and regulates cell cycling as a downstream molecule of TPO signaling. J. Biol. Chem. 276 : 15082-15089, 2001. Morphological and physiological restorations of hereditary form of dilated cardiomyopathy by somatic gene therapy. Biochem. Biophys. Res. Commun. 284 : 431-435, 2001. Antitumor effect of beta2-microglobulin in leukemic cell-bearing mice via apoptosis-inducing activity : activation of caspase-3 and nuclear factor-kappaB. Cancer Res. 61 : 4414-4417, 2001. CD13 is the resistance mechanism for endothelial interleukin-8 inducing apoptosis. In, Cell-Surface Aminopeptidases : Basic and Clinical Aspects. (ed. by Mizutani, S.and Turner, A.J.) Elsevier Science B.V., p. 177-184, 2001. Adeno-associated virus-mediated transfer of endothelial nitric oxide synthase gene reduces vasoconstrictive response. Exp. Clin. Cardiol. 6 : 50-55, 2001. A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus. Hum. Gene Ther. 12 : 1047-1061, 2001. Targeted integration of foreign dna into a defined locus on chromosome 19 in K562 cells using MV-derived components. Int. J. Hematol. 73 : 469-475, 2001. Adeno-associated virus-mediated transfer of endothelial nitric oxide synthase gene inhibits protein synthesis of rat ventricular cardiomyocytes. Cardiovas. Drug Ther. 15 : 19-24, 2001. Colon cancer with meningeal carcinomatosis and myelodysplastic syndrome in a patient who underwent intensive chemotherapy for acute myelogenous leukemia : a case report. Jpn. J. Clin. Oncol. 31: 221-225, 2001. beta2-Microglobulin identified as an apoptosis-inducing factor and its characterization. Blood 94: 2744-2753, 1999. «56789» 所属学協会 40 日本再生医療学会 米国微生物学会 米国血液学会 米国科学振興協会 米国医学研究連合 もっとみる 共同研究・競争的資金等の研究課題 6 遺伝子治療 ミレニアム・プロジェクト 遺伝子治療 厚生労働科学研究費補助金 遺伝子治療 科学研究費補助金 Gene therapy Millennium Project Gene therapy Health and Labour Sciences Research Grants もっとみる